tradingkey.logo
搜索

Tarsus Pharmaceuticals Inc

TARS
添加自选
64.790USD
-0.540-0.83%
收盘 08-07 16:00美东报价延迟15分钟
2.79B总市值
亏损市盈率 TTM

TARS 现金流量表

您可以访问Tarsus Pharmaceuticals Inc的年度和季度现金流量表,以评估其财务稳健性和稳定性。
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
经营活动现金流量(间接法)
持续经营活动现金净额
308.33%61.22M
-19.37%-24.65M
187.14%19.33M
311.01%18.26M
-104.02%-29.39M
45.35%-20.65M
43.61%-22.18M
73.26%-8.65M
39.55%-14.40M
-72.00%-37.79M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
10.29%-10.87M
-361.68%-18.61M
-120.72%-4.26M
-29.61%-15.29M
-21.05%-12.12M
208.22%7.11M
--20.55M
---11.79M
---10.01M
---6.57M
持续经营净收入
8.80%-18.55M
72.27%-6.97M
63.77%-8.37M
46.26%-12.59M
38.90%-20.34M
29.70%-25.12M
44.84%-23.11M
40.18%-23.42M
-5.94%-33.29M
-52.57%-35.73M
-208.13%-41.90M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
8.43%-13.60M
-43.41%-22.51M
-190.51%-5.74M
-295.05%-20.24M
-29.51%-14.85M
-54.85%-15.70M
--6.34M
--10.38M
---11.47M
---10.14M
持续经营损益
120.75%1.00M
-5.00%437.00K
2.55%443.00K
61.97%460.00K
89.54%453.00K
70.37%460.00K
24.50%432.00K
16.39%284.00K
31.32%239.00K
159.62%270.00K
254.08%347.00K
159.57%244.00K
97.83%182.00K
153.66%104.00K
145.00%98.00K
13.25%94.00K
-26.40%92.00K
-35.94%41.00K
-27.27%40.00K
245.83%83.00K
--125.00K
--64.00K
--55.00K
--24.00K
其他非现金项目
793.61%9.56M
39.37%-613.00K
46.56%-629.00K
-41.72%-1.19M
-251.76%-1.38M
-2197.73%-1.01M
-1105.98%-1.18M
-222.69%-839.00K
205.83%908.00K
96.44%-44.00K
111.12%117.00K
-275.68%-260.00K
-544.56%-858.00K
-831.36%-1.24M
-991.53%-1.05M
55.79%148.00K
171.83%193.00K
-96.93%169.00K
110.71%118.00K
-97.00%95.00K
--71.00K
--5.50M
--56.00K
--3.17M
营运资金变化
423.64%52.93M
-1443.25%-29.48M
337.04%13.57M
144.41%19.33M
-259.53%-16.36M
77.76%-1.91M
-104.03%-5.73M
462.85%7.91M
229.12%10.25M
-510.45%-8.59M
-3402.35%-2.81M
3093.18%1.41M
214.90%3.12M
-186.27%-1.41M
129.73%85.00K
-99.78%44.00K
-126.22%-2.71M
105.59%1.63M
-95.91%37.00K
13712.33%20.17M
--10.34M
---29.17M
--905.00K
--146.00K
-应收款项(增)减
383.49%18.92M
-87.00%-30.10M
28.06%-12.77M
-2729.85%-14.10M
651.06%3.91M
-17.94%-16.09M
-56.53%-17.75M
108.75%536.00K
-80.49%521.00K
-2152.18%-13.65M
-2744.06%-11.34M
-80.54%-6.12M
1037.19%2.67M
374.79%665.00K
832.61%429.00K
-116.94%-3.39M
-102.32%-285.00K
99.25%-242.00K
355.56%46.00K
--20.02M
--12.29M
---32.43M
---18.00K
--0.00
-存货(增)减
116.95%198.00K
-133.33%-196.00K
-336.12%-536.00K
105.67%37.00K
-68.79%-1.17M
90.96%-84.00K
107.34%227.00K
-4246.67%-652.00K
---692.00K
---929.00K
---3.09M
---15.00K
----
----
----
----
----
----
----
----
----
----
----
----
-预付费用(增)减
173.81%17.11M
-251.79%-13.24M
206.30%8.19M
794.34%7.98M
-3121.38%-23.17M
719.25%8.72M
-313.86%-7.70M
-44.89%-1.15M
255.89%767.00K
314.40%1.06M
-46.31%-1.86M
-198.51%-793.00K
58.31%-492.00K
-72.25%257.00K
7.83%-1.27M
-6.83%805.00K
2.16%-1.18M
388.47%926.00K
-684.75%-1.38M
173.59%864.00K
---1.21M
---321.00K
--236.00K
---1.17M
-应付款项及应计费用(减)增
----
-31.79%7.71M
-302.96%-30.54M
306.31%23.84M
-67.63%2.29M
-8.32%11.31M
86.62%15.05M
0.93%5.87M
1632.76%7.09M
1279.25%12.34M
2303.01%8.06M
339.79%5.81M
119.44%409.00K
-153.12%-1.05M
-202.52%-366.00K
220.29%1.32M
-377.10%-2.10M
-61.11%1.97M
66.05%357.00K
-202.52%-1.10M
---441.00K
--5.06M
--215.00K
--1.07M
-其他流动资产变化
-46.08%55.00K
12.80%141.00K
-807.14%-381.00K
-1592.00%-373.00K
-78.88%102.00K
17.92%125.00K
61.82%-42.00K
124.51%25.00K
188.79%483.00K
178.95%106.00K
21.43%-110.00K
---102.00K
-511.24%-544.00K
171.43%38.00K
-128.17%-140.00K
100.00%0.00
91.69%-89.00K
101.12%14.00K
1135.42%497.00K
---436.00K
---1.07M
---1.25M
---48.00K
--0.00
-其他流动负债变化
----
----
--0.00
--0.00
100.00%0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
96.55%-1.00K
-2800.00%-232.00K
-93.07%189.00K
1200.00%33.00K
-3.57%-29.00K
81.40%-8.00K
58.33%2.73M
-106.98%-3.00K
-75.00%-28.00K
-134.96%-43.00K
231.35%1.72M
-82.66%43.00K
---16.00K
--123.00K
--520.00K
--248.00K
非持续经营活动现金净额
经营活动现金净额
308.33%61.22M
-19.37%-24.65M
187.14%19.33M
311.01%18.26M
-104.02%-29.39M
45.35%-20.65M
43.61%-22.18M
73.26%-8.65M
39.55%-14.40M
-72.00%-37.79M
-261.73%-39.34M
-73.89%-32.36M
-459.43%-23.83M
-43.73%-21.97M
10.29%-10.87M
-361.68%-18.61M
-120.72%-4.26M
-29.61%-15.29M
-21.05%-12.12M
208.22%7.11M
--20.55M
---11.79M
---10.01M
---6.57M
投资活动现金流量
持续投资活动现金净额
306.49%4.07M
886.10%5.82M
25.35%6.36M
577.30%1.91M
-3.66%1.00M
239.08%590.00K
--5.07M
-93.55%282.00K
32.02%1.04M
-48.82%174.00K
-100.00%0.00
4457.29%4.38M
545.08%787.00K
111.18%340.00K
-53.65%127.00K
-20.66%96.00K
662.50%122.00K
-8.00%161.00K
648.00%274.00K
-10.37%121.00K
--16.00K
--175.00K
---50.00K
--135.00K
资本性支出
306.49%4.07M
886.10%5.82M
25.35%6.36M
577.30%1.91M
-3.66%1.00M
239.08%590.00K
--5.07M
-93.55%282.00K
32.02%1.04M
-48.82%174.00K
-100.00%0.00
4457.29%4.38M
545.08%787.00K
111.18%340.00K
-53.65%127.00K
-20.66%96.00K
662.50%122.00K
-8.00%161.00K
--274.00K
-10.37%121.00K
--16.00K
--175.00K
----
--135.00K
固定资产交易的净现金流
306.49%4.07M
886.10%5.82M
8730.56%6.36M
577.30%1.91M
-3.66%1.00M
239.08%590.00K
--72.00K
-24.80%282.00K
32.02%1.04M
-48.82%174.00K
-100.00%0.00
290.63%375.00K
545.08%787.00K
111.18%340.00K
-53.65%127.00K
-20.66%96.00K
662.50%122.00K
-8.00%161.00K
648.00%274.00K
-10.37%121.00K
--16.00K
--175.00K
---50.00K
--135.00K
无形资产交易净现金流
----
----
----
----
----
----
--5.00M
----
----
----
--0.00
--4.00M
----
----
----
----
----
----
----
----
----
----
----
----
投资产品交易的净现金流
182.73%41.95M
-53.54%-52.74M
202.07%55.63M
-183.08%-2.83M
-28.41%-50.70M
66.34%-34.35M
-405.33%-54.50M
-93.41%3.41M
-160.86%-39.49M
-977.17%-102.05M
120.50%17.85M
190.73%51.74M
--64.88M
--11.63M
---87.09M
---57.03M
----
----
----
----
----
----
----
----
其他投资活动的净现金流
--0.00
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
非持续投资活动现金净额
投资活动现金净额
173.26%37.88M
-67.60%-58.56M
182.71%49.27M
-251.63%-4.74M
-27.59%-51.70M
65.82%-34.94M
-433.75%-59.57M
-93.40%3.13M
-163.23%-40.52M
-1005.12%-102.22M
120.47%17.85M
182.92%47.37M
52634.43%64.09M
7114.91%11.29M
-31731.75%-87.22M
-47112.40%-57.13M
-662.50%-122.00K
8.00%-161.00K
-648.00%-274.00K
10.37%-121.00K
---16.00K
---175.00K
--50.00K
---135.00K
融资活动现金流量
持续融资活动现金净额
69.16%3.30M
-99.12%1.20M
-21.01%2.31M
300.94%2.56M
-95.39%1.95M
25.55%136.56M
-85.19%2.93M
-99.39%639.00K
8197.84%42.32M
2069.78%108.77M
7384.85%19.76M
77227.21%104.89M
-99.32%510.00K
-73.79%5.01M
456.76%264.00K
-281.33%-136.00K
7473300.00%74.73M
100557.89%19.13M
-100.08%-74.00K
-99.81%75.00K
--1.00K
--19.00K
--91.76M
--39.90M
债务发行/偿还的净现金流
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
-100.00%0.00
--75.00M
-100.00%0.00
--0.00
--5.00M
--0.00
-75.00%5.00M
--0.00
--0.00
--0.00
--20.00M
----
----
----
----
--0.00
--0.00
普通股发行/偿还的净现金流
100.00%0.00
-100.00%0.00
--0.00
100.00%0.00
-29.20%-354.00K
37.04%135.13M
-100.00%0.00
-100.04%-43.00K
---274.00K
--98.60M
--19.22M
45685.78%99.38M
----
----
--0.00
---218.00K
--74.57M
----
----
----
----
----
----
----
优先股发行/偿还的净现金流
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
--0.00
--0.00
---244.00K
--40.00M
职工行使股票期权收到的现金
-19.17%1.86M
-16.21%1.20M
-21.01%2.31M
255.34%2.56M
-21.94%2.31M
79.18%1.44M
444.05%2.93M
39.73%721.00K
479.22%2.95M
6069.23%802.00K
103.79%538.00K
529.27%516.00K
113.39%510.00K
--13.00K
15.28%264.00K
9.33%82.00K
23800.00%239.00K
-100.00%0.00
5625.00%229.00K
-67.53%75.00K
--1.00K
--19.00K
--4.00K
--231.00K
发行认股权证所得款项
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--9.37M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
其他融资活动的净现金流额
--1.44M
--0.00
--0.00
100.00%0.00
100.00%0.00
----
--0.00
---39.00K
---35.36M
----
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---75.00K
---875.00K
-100.33%-303.00K
----
----
----
--92.00M
---330.00K
非持续融资活动现金净额
融资活动现金净额
69.16%3.30M
-99.12%1.20M
-21.01%2.31M
300.94%2.56M
-95.39%1.95M
25.55%136.56M
-85.19%2.93M
-99.39%639.00K
8197.84%42.32M
2069.78%108.77M
7384.85%19.76M
77227.21%104.89M
-99.32%510.00K
-73.79%5.01M
456.76%264.00K
-281.33%-136.00K
7473300.00%74.73M
100557.89%19.13M
-100.08%-74.00K
-99.81%75.00K
--1.00K
--19.00K
--91.76M
--39.90M
现金净流量
期初现金流
----
91.21%186.20M
-34.57%115.29M
-45.22%99.21M
-7.93%178.35M
-56.71%97.38M
-22.26%176.21M
69.61%181.09M
193.51%193.71M
213.91%224.95M
33.74%226.67M
-56.48%106.77M
-62.29%66.00M
-58.17%71.66M
-7.79%169.49M
38.83%245.36M
12.04%175.01M
1.89%171.33M
112.86%183.80M
232.49%176.74M
--156.20M
--168.15M
--86.35M
--53.16M
当期现金流变化
229.40%102.40M
-201.29%-82.01M
189.96%70.92M
429.09%16.08M
-527.59%-79.14M
359.17%80.97M
-4469.80%-78.83M
-104.07%-4.88M
-130.93%-12.61M
-451.69%-31.24M
98.24%-1.73M
258.02%119.90M
-42.04%40.78M
-253.97%-5.66M
-684.58%-97.83M
-1173.79%-75.87M
242.58%70.35M
130.78%3.68M
-115.24%-12.47M
-78.71%7.07M
--20.54M
---11.95M
--81.80M
--33.19M
期末现金流
108.24%206.60M
-41.58%104.19M
91.21%186.20M
-34.57%115.29M
-45.22%99.21M
-7.93%178.35M
-56.71%97.38M
-22.26%176.21M
69.61%181.09M
193.51%193.71M
213.91%224.95M
33.74%226.67M
-56.48%106.77M
-62.29%66.00M
-58.17%71.66M
-7.79%169.49M
38.83%245.36M
12.04%175.01M
1.89%171.33M
112.86%183.80M
--176.74M
--156.20M
--168.15M
--86.35M
自由现金流
288.08%57.15M
-43.45%-30.47M
147.60%12.97M
282.98%16.35M
-96.78%-30.39M
44.05%-21.24M
30.71%-27.25M
75.68%-8.93M
37.26%-15.44M
-70.16%-37.96M
-257.56%-39.34M
-96.38%-36.74M
-461.81%-24.61M
-44.43%-22.31M
11.25%-11.00M
-367.59%-18.71M
-121.33%-4.38M
-29.06%-15.45M
-23.79%-12.39M
204.23%6.99M
--20.54M
---11.97M
---10.01M
---6.71M
货币单位
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
审计意见
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

常见问题

什么是经营活动现金流?

经营活动现金流是公司核心业务产生或使用的现金。它以净利润为基础,并对折旧等非现金项目以及应收账款、存货和应付账款等营运资金变动进行调整。强劲的经营活动现金流通常表明,公司能够将销售收入和利润有效转化为实际现金。

Tarsus Pharmaceuticals Inc 产生了多少经营活动现金流?

Tarsus Pharmaceuticals Inc 2025 财年的经营活动现金流为 -12.45M,反映其核心业务经营活动产生的现金。

Tarsus Pharmaceuticals Inc 的经营活动现金流同比有何变化?

Tarsus Pharmaceuticals Inc 的经营活动现金流同比增长 85.00%。

什么是投资活动现金流?

投资活动现金流反映公司投资相关活动所使用或产生的现金,例如资本支出、投资买卖、企业收购和资产处置。投资活动现金流为负并不一定是坏事,因为这可能意味着公司正在为未来增长进行投入。不过,投资者仍需判断这些投资能否带来长期回报。

Tarsus Pharmaceuticals Inc 的资本支出是多少?

Tarsus Pharmaceuticals Inc 最近一个季度的资本支出为 9.86M。

什么是融资活动现金流?

融资活动现金流反映公司如何筹集资金,或向投资者和债权人返还资金,包括发行和偿还债务、发行和回购股份、支付股息以及租赁融资等。融资活动现金流为正,可能表示公司筹集了新资金;为负则可能反映公司正在偿还债务、派发股息或回购股份。

Tarsus Pharmaceuticals Inc 的融资活动现金流有何变化?

Tarsus Pharmaceuticals Inc 最近一个季度用于融资活动的现金为 143.39M。

什么是自由现金流?它对 TARS 有何重要意义?

自由现金流是公司在支付维持或拓展业务所需的资本支出后剩余的现金。它通常用于评估公司的财务灵活性、偿债能力、股息可持续性、股份回购能力和估值水平。投资者还应将自由现金流与净利润、营收增长和资本支出结合分析。

Tarsus Pharmaceuticals Inc 最近一个季度的自由现金流是多少?

Tarsus Pharmaceuticals Inc 最近一个季度的自由现金流为 -22.31M,较上年同期变动 75.10%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有